The protective activity of acellular pertussis vaccine was comparable to that of whole cell vaccine against intracerebral and aerosol infection with Bordetella pertussis in mice. Suckling mice, six to 10 days old, born of mothers immunized with acellular or whole cell pertussis vaccine were challenged with an aerosol of B pertussis strain 18323, and body weight, death, leukocytosis, and viable counts in the lungs were monitored. Protective activity was transferred from mother mice to their offspring through milk and placenta (yolk sac), with substantially greater protection being transferred through the mammary gland. Pertussis, or whooping cough, is caused by a non-invasive infection of the host with Bordetella per-tussis [1, 2]. It is sti...
<div><p>Whooping cough caused by <i>Bordetella pertussis</i> is a re-emerging infectious disease des...
Pneumococcal Surface Protein A (PspA) has been successfully tested as vaccine candidate against Stre...
The immunogenicity of recombinant (r-) pertactin was examined. Parenteral immunization of mice with ...
The results of phase 3 efficacy trials have shown that acellular and whole-cell pertussis vaccines c...
A murine respiratory challenge model was used to examine the induction of cellular and humoral immun...
Despite the extensive use of efficacious vaccines, pertussis still ranks among the major causes of c...
The evaluation of vaccines for human use requires reliable models of infection, that are predictive ...
Most vaccines used for humans work through humoral immunity, yet many appear to be protective even a...
Pertussis is a respiratory infectious disease that has been resurged during the last decades. The ch...
Whooping cough caused by Bordetella pertussis is a re-emerging infectious disease despite the introd...
Whooping cough, an acute respiratory disease affecting over sixty million infants, can be prevented ...
THESIS 7483The development of whole cell vaccine (Pw) and acellular pertussis vaccines (Pa) has had ...
Groups of neonatal mice were immunised with different mucosal vaccines based on acellular (Pertactin...
Fil: Dellepiane, N. I.Fil: Manghi, M A. Hospital General de Niños “Pedro de Elizalde,” (1270) Buenos...
Although B. bronchiseptica efficiently infects a wide range of mammalian hosts and efficiently sprea...
<div><p>Whooping cough caused by <i>Bordetella pertussis</i> is a re-emerging infectious disease des...
Pneumococcal Surface Protein A (PspA) has been successfully tested as vaccine candidate against Stre...
The immunogenicity of recombinant (r-) pertactin was examined. Parenteral immunization of mice with ...
The results of phase 3 efficacy trials have shown that acellular and whole-cell pertussis vaccines c...
A murine respiratory challenge model was used to examine the induction of cellular and humoral immun...
Despite the extensive use of efficacious vaccines, pertussis still ranks among the major causes of c...
The evaluation of vaccines for human use requires reliable models of infection, that are predictive ...
Most vaccines used for humans work through humoral immunity, yet many appear to be protective even a...
Pertussis is a respiratory infectious disease that has been resurged during the last decades. The ch...
Whooping cough caused by Bordetella pertussis is a re-emerging infectious disease despite the introd...
Whooping cough, an acute respiratory disease affecting over sixty million infants, can be prevented ...
THESIS 7483The development of whole cell vaccine (Pw) and acellular pertussis vaccines (Pa) has had ...
Groups of neonatal mice were immunised with different mucosal vaccines based on acellular (Pertactin...
Fil: Dellepiane, N. I.Fil: Manghi, M A. Hospital General de Niños “Pedro de Elizalde,” (1270) Buenos...
Although B. bronchiseptica efficiently infects a wide range of mammalian hosts and efficiently sprea...
<div><p>Whooping cough caused by <i>Bordetella pertussis</i> is a re-emerging infectious disease des...
Pneumococcal Surface Protein A (PspA) has been successfully tested as vaccine candidate against Stre...
The immunogenicity of recombinant (r-) pertactin was examined. Parenteral immunization of mice with ...